Abstract:HIV-1 gp41-like human type I interferon (IFN) could inhibit lymphocyte proliferation and up-modulate MHC class I and II and ICAM-1 molecule expression. Sequence comparison indicates that asimil are pitope RILAV-YLKD exists between N-domain of gp41 and two regions in IFN-α (aa29–35 and 113–129), IFN-β (aa31–37 and 125–138) and IFN-ω(aa29–35 and 123–136), which was shown to form IFN-α/β-receptor binding site. Weak sequence similarity was also found to exist in both regionson gp41 and type I IFN of murine and bovine. Experimental studies, indicated that acommon immunological epitope exists between gp41 and IFN-α and β. Antibodies sagainst human IFN-α and-β recognized the common immunological epitope and inhibited gp41-binding to the potential cellular receptor protein p45. Moreover, the polyclonal antibody to IFN-β completely inhibited gp41-binding to human T, B cells and monocytic cells, while IFN-α could only inhibit this binding incompletely. It was interestingly observed that human IFN-β after preincubating with cells could incompletely inhibit the binding of gp41 to human B cells and monocytic cells, and very weakly inhibit the binding to human T cells, indicating, that the receptor for IFN-β-binding may be, involved in, gp41 binding. This potential relationship may be based on the amino acid sequence homology in the receptor binding region between gp41 and IFN-β. It was observed that the increased levels of antibodies againsthuman IFN-α and-β exist in HIV-1-infected individuals and are associated with the common epitope on gp41. Besides, several studies provided experimental evidence that the common immunological epitope could induce protective activity against HIV-1. The IFN-α-based vaccine has showed a significant reduction of disease progression in IFN-α-vaccine-treated HIV-infected patients. Recent experimental evidence indicates that gp41 and IFN-β were involved in downregulation of CCR5 expression and induction of cells activation or signal transduction. Whe ther it may be performed by a similar mechanism, is still to be investigated.

HIV-1 gp41 shares a common immunologic determinant with human T, B and monocyte cell lines

The Human Monocyte Cell Line U937 Binds HIV-1 Gp41 by Proteins of 37, 45, 49, 62 and 92 Kda.

A Common Immunological Epitope Existing between HIV-1 gp41 and Human Interferon-α and -β

A Common Epitope on Gp41, IFN-α and IFN-β Induces Protective Activity

HIV-1 Gp41 Binds to Several Proteins on the Human B-cell Line, Raji.

HIV-1 Gp41 by a Common Immunological Epitope Induces Increased Levels of Antibodies Against Human Interferon-Β in HIV-1 Positive Individuals

Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.

Biological Function Of Hiv-1 Transmembrane Protein Gp41 - A Study On A Putative Cellular Receptor Of Gp41

HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human raji cell mhc class I and II expression by gp41

Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45.

Antibodies against human IFN-α and -β recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45

Identification of Critical Antibody-Binding Sites in the HIV-1 Gp41 Six-Helix Bundle Core As Potential Targets for HIV-1 Fusion Inhibitors

Biological Function of H1V-1 Transmembrane Protein Gp41

Antibodies to HIV-1 Gp41 Recognize Synthetic Peptides of Human IFN-α and IFN-β

HIV-2 Transmembrane Protein gp36 Binds to the Putative Cellular Receptor Proteins P45 and P62

HIV-1 Gp41 and Type I Interferon: Sequence Homology and Biological As Well As Clinical Implications.

Enhancement of HIV-1 gp41 binding to raji cells by pwm, lps, interferon-γ and interleukin-6

Expression and Identification of Immunological Activities of the HIV‐gp120N‐Human Interferon Gamma Fusion Protein

Short Communication: in VitroSynergy Between Peptides or Neutralizing Antibodies Targeting the N- and C-Terminal Heptad Repeats of HIV Type 1 Gp41

HIV-1 Gp41 Binding to Human T- and B-lymphocytes and Monocytes is Modulated by Phorbol Myristate Acetate (PMA)

Human interferon-β inhibits binding of HIV-1 gp41 to lymphocyte and monocyte cells and binds the potential receptor protein P50 for HIV-1 gp41